Publications by authors named "Xu-Bin Deng"

Claim this Profile
R
RASSF1A inhibits PDGFB-driven malignant phenotypes of nasopharyngeal carcinoma cells in a YAP1-dependent manner.
Ying-Ying Liang, Xu-Bin Deng, Xian-Tao Lin, Li-Li Jiang, Xiao-Ting Huang

Cell Death Dis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of immune cell infiltration in bladder cancer: A gene expression-based study.
Yao Wang, Hong-Jun Ba, Zi-Chuan Liu, Xu-Bin Deng, Min Zhou

Oncol Lett· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RASSF6-mediated inhibition of Mcl-1 through JNK activation improves the anti-tumor effects of sorafenib in renal cell carcinoma.
Ying-Ying Liang, Xu-Bin Deng, Li-Si Zeng, Xian-Tao Lin, Xun-Fan Shao

Cancer Lett· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celecoxib suppresses autophagy and enhances cytotoxicity of imatinib in imatinib-resistant chronic myeloid leukemia cells.
Ying Lu, Ling-Ling Liu, Shou-Sheng Liu, Zhi-Gang Fang, Yong Zou, Xu-Bin Deng

J Transl Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of mesothelioma cancer stem-like cells with adenovirus-mediated NK4 gene therapy.
Xu-Bin Deng, Li Xiao, Yue Wu, Fang Jin, Brooke Mossman

Int J Cancer· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.
Lei Ma, Gong Zhang, Xiao-Bo Miao, Xu-Bin Deng, Yue Wu

FEBS J· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis